DE-LYCRA
27.7.2021 11:02:09 CEST | Business Wire | Press release
The LYCRA Company , a global leader in developing innovative solutions for the textile, apparel, and personal care industries, today introduced a breakthrough LYCRA® FitSense™ technology innovation that reduces or eliminates the need for bra foam. This patent-pending bra cup application can be used in intimate apparel such as traditional wired, non-wired or unlined bras (including bralettes and sport bras), plus activewear and swimwear.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210727005390/en/
LYCRA® FitSense™ technology is a water-based, solvent-free dispersion that is comprised of the same molecule as LYCRA® fiber. The dispersion is screen-printed directly onto the bra fabric, increasing the power of the fabric in precise areas. The power increase in the bra cup effectively reduces nipple protrusion while providing symmetrical support, shaping and lift for the bustline—reducing or eliminating the need for sewn-in panels or insertable pads.
Zones of support can be applied to the bottom and sides of the bra cup for shaping, as well as the wing for maximum comfort and smoothing. LYCRA® FitSense™ technology also can be applied between fabric layers in the bra cup to mask nipple protrusion while retaining the original fabric aesthetics.
“With LYCRA® FitSense™ technology, the print does the work of the pad and enables brands to build a better bra for all sizes, styles and silhouettes—a true breakthrough development,” said Melissa Stewart, global technology director-R&D materials innovations. “With this new innovation, women have more choices in bras that provide functionality, style and comfort.”
Bras can be rigid, bulky, and hot, with multiple components and structures creating an uncomfortable, restrictive wearing experience. LYCRA® FitSense™ technology can be used to design functional bras that are lighter, thinner, and more breathable, without sacrificing modesty, all-day comfort, durability, support or shaping. And unlike polyurethane foam—which discolors and can move around or even get lost in the wash—LYCRA® FitSense™ technology is built into the garment and is highly durable to machine washing and regular wear. Further, in swimwear applications, the technology provides chlorine resistance and fast drying benefits versus foams and dual fabric layers.
LYCRA® FitSense™ technology offers intimate apparel makers versatility to create intentional design aesthetics by incorporating delicate patterns and artistic details that align with their brand identities. “Designs and colors can be easily customized to deliver on-trend fashion cues—from feminine, lacelike designs to sporty geometric shapes—that satisfy all tastes,” said Stewart. “With LYCRA® FitSense™ technology, a designer’s imagination is the only creative limitation.”
LYCRA® FitSense™ technology, which achieved the ECO PASSPORT by OEKO-TEX® sustainability certification, is applied using standard screen-printing processes, eliminating the need for specialty equipment or major supply chain upgrades. The LYCRA Company provides technical guidance to enable brands, retailers, and garment makers to easily access this innovation.
For more information, download our white paper on the LYCRA FitSense™ technology and screen-printed bra cup application.
About The LYCRA Company
The LYCRA Company innovates and produces fiber and technology solutions for the apparel and personal care industries. Headquartered in Wilmington, Delaware, The LYCRA Company is recognized worldwide for its innovative products, technical expertise, sustainable solutions, and unmatched marketing support. The LYCRA Company owns leading consumer and trade brands: LYCRA® , LYCRA HyFit® , LYCRA® T400® , COOLMAX® , THERMOLITE® , ELASPAN® , SUPPLEX® , and TACTEL® . The LYCRA Company’s legacy stretches back to 1958 with the invention of the original spandex yarn, LYCRA® fiber. Today, The LYCRA Company focuses on adding value to its customers’ products by developing unique innovations designed to meet the consumer’s need for comfort and lasting performance. For more information, visit www.thelycracompany.com .
LYCRA® FitSense™ is a trademark of The LYCRA Company.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210727005390/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Special Olympics Airlift Takes Flight Nationwide; Dove 1 Arrives at St. Paul Downtown Airport19.6.2026 17:09:00 CEST | Press release
Approximately 130 Cessna, Beechcraft and Hawker aircraft and volunteer pilots mobilize to transport more than 800 Special Olympics athletes and coaches to the 2026 Special Olympics USA Games The 2026 Special Olympics Airlift officially took flight today as all participating Cessna, Beechcraft and Hawker aircraft, known as Doves, departed from airports across the country. Dove 1 for arrival day, a Cessna Citation Latitude generously operated by Prent Corporation, landed at St. Paul Downtown Airport (STP) carrying Special Olympic athletes and delegation members, signaling the start of Airlift arrivals for the Special Olympics USA Games. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260619085293/en/ Special Olympics Airlift takes flight nationwide; Dove 1 arrives at St. Paul Downtown Airport (Photo credit: Textron Aviation). The arrival signals the start of the world’s largest cumulative peacetime airlift spanning more than 40
Record Currency Management Participates in Innovative European Bank for Reconstruction and Development (EBRD) -Backed Mongolian Tugrik Transaction19.6.2026 16:53:00 CEST | Press release
Record Currency Management Ltd (RCM), subsidiary of London-listed Record plc (Record Financial Group), is pleased to announce its participation in an innovative local currency bond transaction issued by the European Bank for Reconstruction and Development (EBRD), supporting the development of Mongolia's capital markets while providing institutional investors with access to attractive frontier market opportunities. RCM is the UK currency management arm of Record Financial Group, the London-listed specialist investment group managing USD 115 billion of assets on behalf of institutional clients worldwide. Record's client base comprises pension funds, foundations, sovereign institutions and other asset managers, with whom the Group has built long-standing relationships through its focus on bespoke investment and risk management solutions. Headquartered in London, Record has offices in Hamburg, Zurich, Zug, New York, and Hong Kong. The investment forms part of Record Financial Group's broad
Plasma One Launches to Herald a New Era of Stablecoin Banking19.6.2026 14:29:00 CEST | Press release
Plasma has today announced the launch of Plasma One, its flagship financial product designed to make digital dollars usable for everyday spending, sending and earning. Plasma One is designed to make stablecoins feel like money, only better - more accessible, reliable and efficient. For years, stablecoin adoption has been held back by a fragmented system and poor user experience. We have seen wallets in one place, exchanges in another, and costly off-ramps standing between digital dollars and daily life. Plasma One brings that experience together in a single app, giving users a simple way to spend, send and earn with stablecoins from one account with zero fees. Headquartered in London, the city that gave rise to Revolut, Wise and Monzo, Plasma is making a bigger bet, that the next generation of consumer banking will be built on stablecoin rails, not legacy banking infrastructure. Underneath Plasma One is the Plasma Network, Plasma’s own blockchain, purpose-built to move stablecoins inst
IQM Appoints Craig Ciesla, Former Illumina VP, as CTO; Inés de Vega Becomes Chief Scientist19.6.2026 09:00:00 CEST | Press release
Ciesla is a seasoned deep tech executive with more than 25 years of experience delivering products across industries — from startups to Fortune 500 companies. De Vega brings more than 20 years of experience advancing quantum technologies from fundamental research to intellectual property and industrial applications. IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointments of Dr. Craig Ciesla as Chief Technology Officer (CTO) and Dr. Inés de Vega as Chief Scientist, as she transitions from her role as Vice President of Quantum Solutions, deepening IQM´s leadership as the company prepares for its planned Nasdaq listing through a merger with Real Asset Acquisition Corp. (Nasdaq: RAAQ). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260619693929/en/ From left to right: Dr. Inés de Vega, Chief Scientist, and Dr. Craig Ciesla, Chief Technology Officer. Ciesla, an experienced d
Teijin Receives Approval for Additional Indications of XEOMIN® for Cervical Dystonia and Blepharospasm in Japan19.6.2026 09:00:00 CEST | Press release
Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business, and Merz Therapeutics GmbH, a leading player in neurology-focused specialty pharma, jointly announced today that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved the additional indications for XEOMIN® (incobotulinumtoxinA) for the treatment of cervical dystonia and blepharospasm. This approval represents the fourth and fifth indications for XEOMIN® authorized in Japan, alongside its existing approvals for the treatment of upper limb spasticity, lower limb spasticity and chronic sialorrhea. Cervical dystonia is a focal dystonia characterized by involuntary contractions of the neck muscles, resulting in abnormal or repetitive movements and postures.1 Blepharospasm is also a focal dystonia, characterized by excessive involuntary contractions of the muscles surrounding the eye.2 Both conditions significantly impact patients’ quality of life. The approval by MHLW is based on Phase III clinic
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom